| Wed 5 Sep 2012, 15:00 | | ASPEN PHARMACARE HOLDINGS LIMITED - Change in Aspen's BEE shareholding |
|
APN 201209050037A
Change in Aspen's BEE shareholding
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
CHANGES IN ASPEN`S BLACK ECONOMIC EMPOWERMENT ("BEE") SHAREHOLDING
Shareholders are referred to the announcement released on 7 June 2012 wherein it was confirmed
that:
- in order to facilitate the redemption of certain funding obligations, Imithi Investments
(Proprietary) Limited (“Imithi”) had concluded a process of disposing of 9 839 276 Aspen
ordinary shares, as allowed for in terms of the agreements governing the BEE transaction
between Aspen and Imithi (the details of which were more fully disclosed in the
announcement released on 7 June 2012);
- 17 600 000 new variable rate, voting, convertible, redeemable, cumulative A preference
shares would be converted into 17 600 000 ordinary shares (“New Aspen Ordinary Shares”);
and
- Aspen would apply for the listing of the New Aspen Ordinary Shares in Imithi’s name on the
Main Board of the JSE Limited ("JSE"). This listing took effect on 28 June 2012.
Collectively referred to as the “Sale and Conversion Process”.
Following the finalisation of the Sale and Conversion Process, Imithi now holds 21 160 724 Aspen
ordinary shares representing 4.65% of Aspen Shares in issue.
As a further result of this Sale and Conversion Process and subsequent transactions between the
shareholders of Imithi, Dr N J Dlamini, Aspen’s non-executive Chairman now holds an indirect
beneficial interest in 2,626,850 Aspen ordinary shares.
5 September 2012
Sponsor: Investec Bank Limited
Date: 05/09/2012 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
